Tuberculosis Vaccines
Research from Karolinska Institut in tuberculosis vaccines provides new insights
Published in Vaccine Weekly, February 24th, 2010
A report, 'Peptide microarray-based identification of Mycobacterium tuberculosis epitope binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401,' is newly published data in Clinical and Vaccine Immunology. According to recent research from Sweden, "A more effective vaccine against Mycobacterium tuberculosis is needed, and a number of M. tuberculosis vaccine candidates are currently in preclinical or clinical phase I and II studies. One of the strategies to select M. tuberculosis (protein) targets to elicit a CD8(+) or CD4(+) T-cell response is to gauge the binding of candidate peptides to major histocompatibility complex (MHC) class I or class II molecules, a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2010-02-24)
More Articles from Vaccine Weekly
- Elsevier
Predicting effectiveness of flu vaccination campaigns - Infectious Diseases Society of America
Mandatory policy boosts influenza vaccination rate among health care workers - Journal of the National Cancer Institute
News brief: HPV vaccines may reduce a wide range of genital diseases - World Journal of Gastroenterology
New finding of the expression of Helicobacter pylori in Chilean patients - Antibody Engineering
Researchers from West Virginia University describe findings in antibody engineering - Atherosclerosis
Studies from Leiden University in the area of atherosclerosis described - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
